Diagnostic Test Accuracy regional support units (No longer convened)
The Cochrane UK Support Unit was established 7 years ago to provide support to UK-based authors of Cochrane Diagnostic Test Accuracy (DTA) reviews. We also offered support to Cochrane Review Groups based in the UK. The National Institute for Health Research funded the Cochrane UK Support Unit (UKSU) up to 30th September 2014.
Until the end of July 2010, The Continental Europe Cochrane Diagnostic Test Accuracy Support Unit was run with support of funds from the Cochrane Collaboration Steering Group.
Authors enquiring about commencing a new review are asked to contact the Managing Editor of the appropriate Cochrane Review Group (CRG). A full list of CRGs and contacts is available at: http://www.cochrane.org/contact/review-groups
The first step in the DTA review authorship process is to register yourself and your co-authors with the appropriate CRG and request a Review Proposal Form (RPF). The completed RPF should be returned for evaluation by the editors of the CRG and, if approval is granted, the title will be registered and you will be invited to develop a protocol. The protocol should be submitted to the CRG and will undergo peer review by both the CRG and the DTA Editorial Team prior to approval for publication in the Cochrane library.
The RPF requires details of the team that will develop the protocol & review. The team should include a DTA methodologist, a statistician and an information search specialist in addition to relevant clinical expertise. It should also include your plans for training the review team to the standards required for Cochrane DTA review authorship.
Diagnostic Test Accuracy Editorial Team
The DTA Editorial Programme Manager can be contacted by CRGs for specific questions regarding the editorial process. Protocols and reviews ready for the diagnostic editorial process should be forwarded to the DTA Editorial Program Manager, email: DTA-ET@contacts.bham.ac.uk
About this site
This website is updated on behalf of the Cochrane Screening & Diagnostic Tests Methods Group by the DTA Editorial Program Manager, based at the University of Birmingham, UK (DTA-ET@contacts.bham.ac.uk) and Dr. Mariska Leeflang, epidemiologist, based at the Academic Medical Center, The Netherlands (email@example.com).